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Background: Although a number of intestinal inflammatory conditions pertain to the ileum, whole-genome gene
expression analyses in animal models of ileal inflammation are lacking to date. Therefore, we aimed to identify and
characterize alterations in gene expression in the acutely inflamed ileum of two murine models of intestinal
inflammation, namely intestinal schistosomiasis and TNBS-induced ileitis, compared to healthy controls. To this end,
we used whole-genome microarrays, followed by bioinformatics analyses to detect over-represented Kyoto
Encyclopedia of Genes and Genomes pathways and Gene Ontology categories.
Results: Following screening of almost all known mouse genes and transcripts represented on the array, intestinal
schistosomiasis and TNBS-induced ileitis yielded 207 and 1417 differentially expressed genes, respectively, with only
30 overlapping concordantly changed genes. Functional category groups consisting of complement and
coagulation cascades, extracellular matrix (ECM)-receptor interaction, Fc epsilon receptor I signaling pathways and
protein activation cascade, cell adhesion categories were over-represented in the differential gene list of intestinal
schistosomiasis. Antigen processing and presentation, cell adhesion molecules, ABC transporters, Toll-like receptor
signaling pathways and response to chemical stimulus categories were over-represented in the differential gene list
of TNBS-induced ileitis. Although cytokine-cytokine receptor interaction, intestinal immune network for IgA
production, focal adhesion pathways and immune, inflammatory and defense response categories were
over-represented in the differential gene lists of both inflammation models, the vast majority of the associated
genes and changes were unique to each model.
Conclusions: This study characterized two models of ileal inflammation at a whole-genome level and outlined
distinct gene expression profiles and patterns in the two models. The results indicate that intestinal schistosomiasis
involves Th2 responses, complement activation, protein activation and enhanced ECM turnover, while
TNBS-induced ileitis involves Th17 responses, defective antigen processing and presentation and altered Toll-like
receptor-mediated responses. Signs of an impaired epithelial barrier are apparent in both inflammation models.
Furthermore, the comprehensive differential gene list and functional groups provided by this study constitute an
interesting starting point to explore new targets and extended functional networks dealing with small bowel
inflammation.
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Studies in humans and animal models of intestinal in-
flammation have greatly improved our understanding of
some of the underlying dysregulated immune mechan-
isms, which in turn has promoted the development of
new therapeutic strategies. Some of these studies, which
were based on whole-genome microarrays for the identi-
fication of altered gene expression and transcript regula-
tion at the whole-genome level, have been instrumental
in characterizing inflammatory conditions at the mo-
lecular genetic level, in obtaining a global picture of the
underlying functional processes, as well as in identifying
many of the key molecules involved. However, to date,
most of these studies involving whole-genome gene ex-
pression assays in humans and in animal models of in-
testinal inflammation have generally targeted the large
intestine rather than the small intestine, simply because
of tissue accessibility and because of the fact that the
majority of the frequently used animal models of both
acute and chronic intestinal inflammation involve the
large intestine rather than the small intestine [1-5]. As a
result, only little is known about the molecular genetic
changes underlying small bowel inflammation at the
whole-genome level [6]. Nonetheless, it is widely known
that a number of major intestinal inflammatory condi-
tions pertain to the ileum, which contains the most
complex part of the gut-associated lymphoid tissue, the
Peyer's patches, and also harbors a very high luminal
concentration of microorganisms [7]. For instance,
human Crohn's disease (CD) is most frequently localized
in the terminal ileum [7], and it also becomes increas-
ingly evident that human ulcerative colitis (UC) might
also involve the terminal ileum due to further extension
of the inflammatory process either by backwash from
the colon or by other factors [8,9]. A few murine models
of small bowel inflammation bearing resemblance to CD
have provided vital information on some of the mechan-
isms underlying small bowel inflammation, but, to the
best of our knowledge, whole-genome gene expression
studies in the full-thickness ileum have been performed
neither in these animal models, nor in other animal
models involving any other type of small bowel inflam-
mation to date [10-13].
Studies in mouse revealed that gene expression patterns
vary between the anatomically defined regions of the
gastrointestinal (GI) tract, such as the stomach, small in-
testine and large intestine [14]. Moreover, a study based
on gene expression in humans suggests that immune
regulation is different in ileal and colonic inflammation,
which might have important consequences for therapeutic
intervention [15]. Consequently, gene expression data on
large bowel inflammation cannot be completely extrapo-
lated to other regions of the GI tract, and as such a
detailed analysis of the genes involved in small intestinalinflammation is highly desirable. These findings, along
with the above-mentioned lack of whole-genome gene ex-
pression studies in full-thickness ileum in animal models
of intestinal inflammation, stress the urgent need to elab-
orate on the molecular genetic changes underlying ileal in-
flammation in view of developing better therapeutic
strategies. Therefore, the objective of this whole-genome
microarray study was to identify and characterize gene ex-
pression changes in the acutely inflamed ileum of two di-
verse murine models of intestinal inflammation, namely,
Schistosoma mansoni-induced intestinal schistosomiasis,
which is a non-inflammatory bowel disease model and
2,4,6-trinitrobenzene sulfonate (TNBS)-induced ileitis,
which is an inflammatory bowel disease (IBD) model,
compared to healthy controls.
Schistosomiasis is a highly prevalent tropical disease
caused by the blood-dwelling trematode of the genus
Schistosoma, and, although successfully controlled in
many countries, remains a major public health problem
with an estimated 200 million infected people worldwide
[16]. After infection by larvae of S. mansoni, adult
worms reach and reproduce in the mesenteric vessel bed
and parasite eggs get entrapped in the portal and mesen-
teric venous systems. A proportion of these eggs pene-
trate through the liver and intestinal wall to enter the
lumen, thereby generating a granulomatous inflamma-
tion and subsequent fibrosis [17-19]. Intestinal schisto-
somiasis has been widely studied in the context of
granulomatous inflammation. Moreover, Schistosoma-
derived eggs and soluble worm proteins have been
shown to alleviate intestinal inflammation in animal
models of IBD [20,21]. Animal models of granulomatous
inflammation, such as schistosomiasis, permit a detailed
analysis of basic immune mechanisms involved in
chronic immunoregulation that is also relevant to other
species [22,23]. Therefore, further study of murine intes-
tinal schistosomiasis at the molecular genetic level will
lead to a better understanding of its immunomodulatory
and immunoregulatory mechanisms.
TNBS is a haptenating agent that immunogenizes au-
tologous or microbiota proteins in the mucosa after dis-
ruption of the intestinal epithelial barrier by ethanol.
Intraluminal instillation of TNBS in ethanol is known to
generate classical models of intestinal inflammation
mimicking some aspects of CD [24]. TNBS is one of the
best-known chemical agents used for the induction of
colitis and ileitis in animal models [25-27]. TNBS-
induced inflammation has been widely studied for its re-
semblance to CD and is considered an apt model to
study the acute local inflammatory response as well as
the subsequent established and delayed-type hypersensi-
tivity reactions [26].
The present study reports on altered whole-genome gene
expression and the associated functional categories and
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induced by the two aforementioned etiologic factors, i.e., S.
mansoni parasite-derived eggs, and a chemical agent,
TNBS. Our findings collectively provide a solid basis and a
starting point for a better understanding of a number of
crucial and novel functional processes underlying ileal in-
flammation initiated by different causative agents.
Methods
Animal handling
All experiments were approved by the ethics committee
of the University of Antwerp. Adult female C57BL/6 J
mice, purchased from JANVIER (Le Genest St Isle,
France), were given a standard pellet diet plus water ad
libitum, and were housed in a 12 h/12 h light/dark cycle
at constant temperature (22°C). The animals were
divided into three groups: a healthy control group and
two inflamed groups, i.e., a group with S. mansoni-
induced intestinal schistosomiasis and a group with
TNBS-induced ileitis (n = 3 in each group).
Mice were infected with S. mansoni according to the
method of Yolles et al. [28]. Briefly, the mice were
anesthetized with an intraperitoneal injection of sodium
pentobarbital (60 mg kg-1; NEMBUTAL; Sanofi, Brus-
sels, Belgium) followed by an intraperitoneal injection of
1 ml of sterile water containing 130 freshly shed cer-
cariae of a Puerto Rico strain of S. mansoni. The cycle of
S. mansoni was maintained by passage through Biom-
phalaria glabrata snails.
TNBS-ileitis was induced by laparotomy according to
a modified procedure of Pontell et al. [29,30]. Briefly,
after fasting for 24 h, mice were anesthetized using a
mix of medetomidine hydrochloride (0.5 mg kg-1;
DOMITOR; Pfizer, New York, NY, USA) and ketamine
hydrochloride (50 mg kg-1; ANESKETIN; Eurovet, Bla-
del, the Netherlands) dissolved in physiological solution
and administered intraperitoneally. After having been
shaved and disinfected, the lower abdomen was incised
and the ileum was exteriorized on sterile gauze. A vol-
ume of 0.1 ml of 25 mg ml-1 TNBS (Sigma-Aldrich, St.
Louis, MO, USA) dissolved in 25% ethanol was injected
transmurally into the lumen of the ileum approximately
2 cm proximal to the ileo-cecal junction. The ethanol-
carrier is included in the basic protocol and is an essen-
tial part of the TNBS-inflammation model since it
compromises the epithelial barrier, allowing the access of
hapten and luminal contents to subepithelial immune
cells, thus initiating the immune response [26]. The lapar-
otomy was sutured in two layers using non-resorbable
sutures. Before closing the midline incision, a solution
containing marbofloxacine (2 mg kg-1; MARBOCYL;
Vetoquino S.A., Lure cedex, France) was injected into the
peritoneal cavity. After surgery, animals were maintained
in a controlled environment for 24 h.S. mansoni-infected animals were sacrificed 8 weeks
post infection at the acute stage of intestinal schistosom-
iasis. TNBS-treated animals were sacrificed 24 h post in-
duction at the acute stage of ileitis. All control and
inflamed animals were age-matched at the time of tissue
retrieval. Since the handling procedures used to induce
inflammation in our study are established methods that
are not known to induce any inflammatory changes per
se, and also taking the high cost of microarray experi-
ments, as well as the reduction of the number of animals
for ethical reasons into consideration, we did not con-
sider it necessary to include any additional controls for
the inflammation induction procedures in our micro-
array study [29,30]. Although the impact of the survival
surgery protocol in the TNBS-treated group was not
controlled for in the healthy control group in our study,
other studies using the same established surgery proto-
col and sham treatment revealed a minimal impact of
the procedure in itself on these animals [25,27,29,30].
Therefore, we estimate that the gene-expression data in
our study might have had a minimal chance of deriv-
ation from the surgery protocol by itself. All animals
were euthanized in the morning by cervical dislocation,
followed by exsanguination. Full-thickness terminal
ileum was dissected out and rinsed with Krebs solution
(117 mM NaCl, 5 mM KCl, 2.5 mM CaCl2·2H2O,
1.2 mM MgSO4·7H2O, 25 mM NaHCO3, 1.2 mM NaH2-
PO4·2H2O and 10 mM glucose; pH 7.4). Pieces of ileum
weighing around 100 mg each were snap-frozen in liquid
nitrogen and stored at −80°C for RNA extraction. A
small part of the ileum taken from the same anatomical
location as the samples used for the microarray experi-
ments, was fixed for 2 h at room temperature in 4% par-
aformaldehyde in 0.1 M phosphate buffer (pH 7.4) and
processed for paraffin embedding. Five μm-thick paraffin
sections were stained with hematoxylin-eosin to verify
the degree of inflammation. Two pathologists blinded to
the disease status and experimental results evaluated the
histological specimens by light microscopy.
RNA extraction
Total RNA was isolated using the TRIzolW extraction
method (Life Technologies, Merelbeke, Belgium). In
brief, tissues were ground to a fine powder with mortar
and pestle in liquid nitrogen, and the homogenized tis-
sues mixed with TRIzolW were used for total RNA isola-
tion according to the manufacturer's protocol. RNA
extracts were purified using DNAse I and RNAse inhibi-
tor (Fermentas, St. Leon-Rot, Germany) followed by
phenol–chloroform extraction [31]. RNA integrity and
purity were verified by denaturing formaldehyde-agarose
gel electrophoresis and measurement of 260/230 nm
and 260/280 nm absorbance ratios by ND-1000 spectro-
photometry (NanoDrop Technologies, Rockland, DE,
Avula et al. BMC Genomics 2012, 13:377 Page 4 of 21
http://www.biomedcentral.com/1471-2164/13/377USA). RNA samples were used only if the ribosomal
bands showed no degradation on the gel and the 260/
280 and 260/230 absorbance ratios were between 1.7
and 2.1. A total of 10 ileal total RNA samples were pre-
pared (3 control samples, 3 S. mansoni-infected samples,
3 TNBS-treated samples and one reference sample con-
taining a pool of equimolar amounts of all control total
RNA samples).
Fluorescent cRNA labeling and oligonucleotide
microarrays
The two-colour microarray-based gene expression ana-
lysis protocol (version 5.7, http://www.agilent.com) was
followed to construct and fluorescently label cRNA from
total RNA extracts. Briefly, probes were prepared by
converting an aliquot of 1 μg total RNA from each sam-
ple into labeled cRNA, using reagents from the two-
colour spike-in kit (catalogue No. 5188–5279, Agilent
Technologies, Diegem, Belgium) and a two-colour Quick
amp labeling kit (catalogue No.5190-0444, Agilent Tech-
nologies). Total RNA was reverse transcribed into first-
and second-strand cDNA, after which first-strand cRNA
was constructed using the second-strand cDNA as a
template, in the presence of either Cy3-CTP or Cy5-
CTP. Using this method the target material was simul-
taneously amplified at least a hundred times. The labeled
cRNA probes were purified to ensure removal of un-
bound Cy dyes using the RNeasy mini spin column kit
(catalogue No.74104, Qiagen Benelux B.V., Venlo, the
Netherlands). Labeling efficiency was determined at
550 nm (Cy3) and 650 nm (Cy5) by ND-1000 spectro-
photometry (NanoDrop Technologies).
A custom whole-genome gene expression high-
definition oligo microarray platform, (design ID 021695,
catalogue No. G2514F), was created and made publicly
available in the Gene Expression Omnibus (GEO) data-
base (GPL14111). This custom microarray 4X44K plat-
form represented almost all known genes in the mouse
genome and their resulting transcripts in over 41000 60-
mer oligonucleotide probe features. Experiments were
performed on this platform using a reference design as
indicated by Knapen et al. [32]. This design consisted of
a total of 11 arrays for three biological replicates of con-
trol, S. mansoni-infected and TNBS-treated tissue sam-
ples as well as two dye flipped technical replicates of a
control and a S. mansoni-infected tissue sample (see
Gene Expression Omnibus (GEO) series accession num-
ber GSE31265). Using the Gene expression hybridization
kit (catalogue No. 5188–5242, Agilent Technologies) a
hybridization sample volume of 100 μl was applied on
each array containing a total of 825 ng of test sample
hybridized against the complementarily labeled reference
cRNA. Subsequently, the microarray slides were
assembled in the slide chamber and incubated at 65°Cfor 17 h in a rotating hybridization chamber (Genetix
Ltd, New Milton, Hampshire, UK). Slides were strin-
gently washed with wash buffers and acetonitrile and fi-
nally submersed in stabilization and drying solution
(Agilent Technologies) to prevent ozone-induced Cy5
degradation. Subsequently, the slides were placed in a
nitrogen purge box for temporary storage and scanned
immediately.
Microarray analysis
Slides were scanned in the Genepix Personal confocal
4100A scanner (Axon Instruments, Union City, CA,
USA) at a resolution of 5 μm and at a wavelength close
to 532 nm and 635 nm for Cy3 and Cy5 channels, re-
spectively. The photomultiplier tube voltages were
adjusted to obtain an overall green/red ratio of one.
Images were processed using the GenePix Pro 4.1 soft-
ware (Axon Instruments) for the identification and
quantification of the fluorescent signal intensities of the
spots [31]. The resulting files were saved as Genepix
results (GPR) files, and were imported into the BioArray
Software Environment database (BASE 1.2.12, accessible
at http://www.islab.ua.ac.be/base/), a free MIAME
platform-based microarray analysis method customized
by the Intelligent Systems Laboratory (University of Ant-
werp, Antwerp, Belgium). Through this database, statis-
tical analysis was performed using the R package limma
(linear models for microarray data). Limma is a moder-
ated T-statistic approach that detects differentially
expressed genes between test groups, given the natural
variance within these test groups, adjusted for multiple
testing [31,33-35]. Spots for which red or green FG <
BG + 2SD as well as spots that were flagged due to arti-
facts received a weight of zero before analysis (FG: me-
dian foreground intensity, BG: average local background
intensity calculated over the full microarray, SD: stand-
ard deviation of local background intensities) [36]. The
median background signal was subtracted from the me-
dian foreground signal. The median intensity data were
corrected for background using a normal-exponential
convolution model with method “normexp”, offset = 50
using the function backgroundCorrect, and loess-
normalized using the function normalizeWithinArrays,
after which the data were normalized for between-
array normalization using vsn (variance stabilization)
[31,37,38]. The two inflammation models were con-
trasted against the controls, linear models were fitted to
intensity ratios, after which probes were ranked in order
of evidence of differential expression using an empirical
Bayes method [33]. Probes were considered differentially
expressed when the p-value was < 0.05, adjusted p-value
(calculated for multiple testing corrections (MTC) on
the obtained p-values by the Benjamini and Hochberg
false discovery rate method) was < 0.1 and log2FC
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in a list of differentially expressed probes for each
inflammation model. The microarray data have been
deposited in the National Center for Biotechnology
Information GEO (NCBI GEO; http://www.ncbi.nlm.
nih.gov/geo) and are accessible under the GEO series
accession number GSE31265.
Bioinformatics data mining and over-representation
analysis
Growing evidence that certain sets of genes acting in
concert contribute to the etiology of disease conditions
has led to an increased interest in identifying networks
or groups of genes, rather than single genes. Moreover,
often subtle changes in gene expression, or sometimes
the lack of such changes, can equally contribute signifi-
cantly to changes in function, and these biologically
meaningful changes sometimes go undetected by single-
gene analysis [39,40]. Therefore, we set out to identify
biologically relevant category groups in the two inflam-
mation models of our study by performing a function-
based characterization of the differentially expressed
genes. To this end, using the stand-alone version of the
GO-Elite tool (http://www.genmapp.org/go_elite) [41],
we performed a pathway or functional over-representation
analysis of the differentially expressed genes for Kyoto
Encyclopedia for Genes and Genomes (KEGG) pathways
and GO categories. We chose the KEGG pathway analysis
rather than analysis of other pathway databases since
KEGG is considered to be one of the biggest available
pathway databases compiled from several literature
sources, especially for mouse [42,43]. Since the stand-
alone version of GO-Elite does not work for an over-
representation analysis of KEGG pathways, we first
downloaded the KEGG gpml archive from the PathVisio
website (http://www.pathvisio.org), replaced other path-
way flat-file relationships already existing in GO-Elite with
that of KEGG, and then were able to perform a functional
analysis of KEGG pathways in GO-Elite. The input gene
set for our over-representation analysis consisted of the
differential gene list corresponding to either of the two in-
flammation models, while the whole genome was used as
the denominator or reference background. We used the
GO-elite tool with the default options: significance thresh-
old of z-score > 2 and at least three genes from the input
list in the enriched KEGG pathway or GO category. GO-
elite generated a full list of KEGG and GO annotations
associated with all differentially expressed genes, calcu-
lated over-representation statistics and provided a min-
imal list of relevant pruned annotations (filtered for
highest scoring terms along each division or branch of the
hierarchy and non redundancy in enriched terms) for each
inflammation model. The pruned list included main statis-
tics, such as z-score > 2 (calculated using the expectedvalue and standard deviation of the number of genes
meeting the criterion on a pathway under a hypergeo-
metric distribution), permutation p-value (calculated
by selecting the original number of input identifiers
at random from the denominator identifiers 2000
times), adjusted permutation p-value (calculated using the
Benjamini-Hochberg method), average log2FC (for each
enriched term based on associated differential genes) and
average adjusted p-value (for each enriched term based
on associated differential genes) for the KEGG and
GO terms [41,44]. From this pruned list, we finally set
three strict threshold criteria for significance in our over-
representation analysis, i.e., a z-score > 2, at least three
genes from the input list in the KEGG pathway or GO cat-
egory and an adjusted permutation p-value ≤ 0.35 [41,44].
These criteria enabled us to identify highly relevant cat-
egory groups (KEGG pathways +GO biological process
categories) in the two inflammation models of our study.
Further, GenMAPP (http://www.genmapp.org/) was used
for visualization of the gene expression data in the over-
represented KEGG pathways, [41-45].
In addition to the above-mentioned analyses, we
briefly compared the list of differentially expressed genes
in the two inflammation models of our study with the
list of genes previously known to be associated with IBD
to assess the degree of similarity between our inflamma-
tion models and IBD.
Results and discussion
The data presented in this study are derived from the
analysis of full-thickness murine ileal tissue during
physiological and pathophysiological states – i.e., healthy
control and the acute stages of intestinal schistosomiasis
and TNBS-induced ileitis, respectively, which allowed us
to characterize and compare the two models in an intact
heterogeneous ileal tissue system. Whole-genome micro-
arrays containing almost all known mouse genes with
their resulting transcripts were screened for differential
expression in order to unequivocally disclose the differ-
entially expressed genes in the two models and to iden-
tify the key functions involved, in terms of KEGG
pathways and biological processes.
Histology-hematoxylin-eosin stainings
No pathological signs of inflammatory activity were
observed in the ileum of control mice (Figure 1a), while
the ileum of S. mansoni-infected mice was characterized
by the presence of granulomas consisting of macro-
phages, eosinophilic granulocytes and lymphocytes sur-
rounding the entrapped parasite eggs in the submucosa
and mucosa, by thickening of the tunica muscularis and
by broadening of the intestinal villi (Figure 1b). The dif-
fuse mucosal inflammation consisted of granulocytes
and scarce lymphocytes. These observations were
Figure 1 Hematoxylin-eosin-stained paraffin sections of control and inflamed ileum. a: The control ileum showed no pathological signs of
inflammatory activity b: The S. mansoni-infected ileum was characterized by the presence of granulomas with entrapped parasite eggs (asterisk),
thickening of the tunica muscularis and broadening of the villi c: The TNBS-treated ileum showed ablated and broken villi, signs of regeneration
of the mucosal epithelium (arrows), subepithelial cysts and a high number of immune cells in the lamina propria as well as in the vicinity of
enteric ganglia. Scale bar = 200 μm.
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in the ileum of TNBS-treated mice were similar to those
described in guinea-pig [30]. The villi showed a des-
tructed structure and were ablated, resulting in debris in
the lumen, although signs of restoration and regener-
ation of the mucosal epithelium were observed. Sube-
pithelial cysts and a high number of infiltrated
granulocytes, macrophages, along with some lympho-
cytes within the lamina propria or closely associated
with enteric ganglia, were also seen (Figure 1c). As such,
all inflamed animals showed obvious acute inflammatory
changes, consistent with previous literature data, at the
time of tissue retrieval.
As ethanol was used as a vehicle for inducing inflam-
mation in the TNBS-ileitis model, to control for changes
induced by ethanol toxicity in itself, the ileum of mice
treated with 25% ethanol alone was also examined by
hematoxylin-eosin stainings. Observations in these mice
showed no histopathological changes in the ileum after
24 h (data not shown). These findings are consistent
with other studies in mice [27].
Microarray analysis and gene expression profiling
Statistical limma analysis indicated that 236 and 1685
probes showed differential expression in the S. mansoni-
infected and the TNBS-treated ileum, respectively
(log2FC > 1 or < −1; p-value < 0.05, adjusted p-value < 0.1,
MTC Benjamini-Hochberg). After removal of duplicates,
this differentially expressed probe list was found to cor-
respond to a total of 207 unique genes (172 upregulated
and 35 downregulated) in the S. mansoni-infected ileum,
and to a total of 1417 unique genes (611 upregulated
and 806 downregulated) in the TNBS-treated ileum.
Analysis of shared gene expression profiles revealed that
48 genes shared differential expression between the two
models, i.e., 20 commonly shared upregulated genes, 10commonly shared downregulated genes and 18 genes
that showed opposite changes in the two inflammation
models (17 genes upregulated in the S. mansoni-infected
ileum and downregulated in the TNBS-treated ileum,
and 1 gene downregulated in the S. mansoni-infected
ileum and upregulated in the TNBS-treated ileum).
Detailed information on all differentially expressed genes
is found in the additional files (see Additional file 1 and
Additional file 2).
The above findings clearly demonstrate that, in gen-
eral, the number of genes showing differential expression
is higher in the TNBS-treated ileum than in the S. man-
soni-infected ileum (approximately 6 times more), imply-
ing that TNBS-induced ileitis has a more profound
impact on ileal gene expression than intestinal schisto-
somiasis. Furthermore, the vast majority of differentially
expressed genes in the S. mansoni-infected ileum were
upregulated, while downregulated genes narrowly out-
numbered upregulated genes in the TNBS-treated ileum.
More interestingly, only a minority (30 genes) of all the
differential genes overlapped between the S. mansoni-
infected ileum and the TNBS-treated ileum in a con-
cordant manner. Together, these findings indicate that
the gene expression profiles in the two inflammation
models are considerably different, likely owing to the dif-
ferent inflammation-inducing agents.
Gene ontology (GO) and pathway over-representation
analysis
The full list of KEGG and GO annotations in GO-Elite
showed that of the whole mouse genome represented on
the arrays, 5699 individual genes were contained within
the GO-elite KEGG database and 17730 individual genes
were contained within the GO-elite GO database, and
were used for analysis. Of the 207 unique genes that
were differentially expressed in the S. mansoni-infected
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term and 144 genes to a GO term. Of the 1417 unique
genes that were differentially expressed in the TNBS-
treated ileum, 232 genes could be linked to a KEGG
pathway term and 1050 genes to a GO term. Additional
files 3 and 4 detail all the differentially expressed genes
that could be linked to a KEGG pathway and/or GO
term in the S. mansoni-infected and the TNBS-treated
ileum respectively (see Additional files 3 and 4).
The above findings clearly show that although the vast
majority of the differentially expressed genes in the two
inflammation models of our study could be linked to a
GO term and/or a KEGG pathway term, there still
remained a significant number of differentially expressed
genes that could not be associated with a KEGG pathway
term (≈80% in the S. mansoni-infected ileum and ≈ 84% in
the TNBS-treated ileum) or a GO term (≈30% in the
S. mansoni-infected ileum and ≈ 26% in the TNBS-
treated ileum).
Based on the above-described threshold criteria for
over-representation analysis described in the methods
section, nine KEGG pathways were over-represented in
the upregulated gene list of the S. mansoni-infected
ileum. Only one KEGG pathway was over-represented in
the downregulated gene list of the S. mansoni-infected
ileum. Twenty-six GO biological process categories were
over-represented in the upregulated gene list of the S.
mansoni-infected ileum, and three GO biological process
categories were over-represented in the downregulated
gene list of the S. mansoni-infected ileum. Detailed in-
formation on all over-represented KEGG pathways and
GO categories in the S. mansoni-infected ileum are
found in additional file 5 (see Additional file 5).
Twenty-six KEGG pathways were over-represented in
the upregulated gene list of the TNBS-treated ileum.
Twenty-eight KEGG pathways were over-represented in
the downregulated gene list of the TNBS-treated ileum.
Ninety-seven GO biological process categories were
over-represented in the upregulated gene list of the
TNBS-treated ileum and seventy-one GO biological
process categories were over-represented in the downre-
gulated gene list of the TNBS-treated ileum. Detailed in-
formation on all over-represented KEGG pathways and
GO categories in the TNBS-treated ileum are found in
additional file 6 (see Additional file 6).Identification of functionally meaningful category groups
Given the high number of over-represented KEGG and
GO terms, we considered it relevant to make a shortlist
of the most significant category groups. Based on the
high overlap of individual genes observed among some
of the high scoring KEGG pathways and GO categories,
five functionally meaningful category groups (KEGGpathways + GO categories) were finally obtained in the S.
mansoni-infected ileum (Additional file 7: Table S1):
1. Cytokine-cytokine receptor interaction pathway and
immune and defense response categories;
2. Intestinal immune network for immunoglobulin A
(IgA) production pathway and immune response
category;
3. Complement and coagulation cascades pathway and
protein activation cascade category;
4. Extracellular matrix (ECM)-receptor interaction
pathway and cell adhesion category;
5. Fc epsilon RI (FcεRI) signaling pathway and
regulation of acute inflammatory response category.
Six functionally meaningful category groups were finally
obtained in the TNBS-treated ileum (Additional file 8:
Table S2):
1. Cytokine-cytokine receptor interaction pathway and
inflammatory and immune response categories;
2. Intestinal immune network for IgA production
pathway and immune response category;
3. Antigen processing and presentation pathway and
antigen processing and presentation of endogenous
antigen, of exogenous peptide antigen and of peptide
or polysaccharide antigen via major
histocompatibility complex (MHC) class II
categories;
4. Cell adhesion molecules pathway and cell adhesion
category;
5. Toll-like receptor (TLR) signaling pathway and
immune and inflammatory response categories;
6. ABC transporters pathway and response to chemical
stimulus category.
These functional category groups will be elaborated on
below. The category groups pertaining to both inflam-
mation models will be discussed first, followed by those
that are relevant only to the S. mansoni-infected ileum
and then those relevant only to the TNBS-treated ileum.
Wherever necessary, in order to group important infor-
mation, changes pertaining to genes that are not con-
tained in the category group but are of relevance will
also be discussed.
Cytokine-cytokine receptor interaction pathway and
immune response category group
(Additional file 1, Additional file 2, Additional file 7:
Table S1 and Additional file 8: Table S2) (Figure 2).
In the S. mansoni-infected ileum, our findings suggest
a predominant presence of polarized Th2 responses dur-
ing acute intestinal schistosomiasis, and that the
cytokine-cytokine receptor interaction pathway-immune
Figure 2 Illustration of the KEGG cytokine-cytokine receptor interaction pathway with location of 6 and 18 associated genes that were
differentially expressed in the S. mansoni-infected and the TNBS-treated ileum, respectively.
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These findings are in agreement with previous reports
showing that the inflammatory reaction to schistosome
eggs in the mouse intestine is predominantly a Th2-type
response [46]. The cytokine-cytokine receptor inter-
action pathway and immune (and defense) response cat-
egory group shared 6 genes (Ccl24, Ccr5, Il18r1, Il4,
Il6ra, Tnfsf13b), all of which showed increased expres-
sion. Increased expression of Il4, Ccl24 and Ccr5 is indi-
cative of Th2-type responses [47-49] and IL4 is a
hallmark cytokine for Th2-type T cell responses [47].
Upregulation of Ccl24 (eotaxin-2) is associated with re-
cruitment of immune cells including eosinophils and
Th2 cells in the GI mucosa during helminth infection
[48]. The increased expression of the Ccr5 found in our
study lends further support to literature data showing
that CCR5 plays a role in limiting the granulomatous and
Th2 responses, thereby reducing severity of experimentalschistosomiasis [49]. Furthermore, the increased expres-
sion of resistin-like beta (Retnlb/Fizz2) in the S. mansoni-
infected ileum supports the notion that the protein
encoded by this gene, intestinal goblet cell-derived RELM-
beta/FIZZ2, is a Th2 cytokine-induced immune-effector
molecule produced in resistance to S. mansoni infection
[50]. RELM-beta/FIZZ2 has also been associated with the
initiation of ileitis in animal models of CD [10]. The highly
increased expression of other Th2 cytokine-associated
genes, such as chitinase-3-like genes Chi3l3 and Chi3l4
indicate their probable involvement in host/microbial
interactions and thereby in the disease pathogenesis in
this model [51].
In the TNBS-treated ileum, our findings suggest that
proinflammatory responses, Th17 priming and regulatory
mechanisms are enhanced during acute TNBS-induced
ileitis, and that the cytokine-cytokine receptor interaction
pathway-immune (and inflammatory) response category
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category group shared 8 genes (Ccl3, Ccl4, Ccl9, Cxcl5,
Il1b, Il6, Pf4, Ppbp), all of which showed increased expres-
sion. Increased expression of Il6 and Il1b and of genes
such as the transcription factor Stat3, in the TNBS-
treated ileum indicate changes that are associated with
Th17 cell induction and differentiation [52-54]. Data on
other effector cytokines of Th17 cells, such as Il17a, were
not available in our differential gene list, probably result-
ing from the very low gene expression levels of Th17 ef-
fector cytokines. The observation that Ccr6 shows
decreased expression in the TNBS-treated ileum, together
with the increased expression of Il6, could be indicative of
increased Th17 effector responses and decreased Foxp3-
induced regulatory responses in the TNBS-treated ileum
[55,56]. Furthermore, some of the selected genes induced
in Th17 cells compared to Th0 cells, such as the above-
mentioned Ccl9 and Tnfrsf12A, showed increased expres-
sion in this condition [57]. Taken together, the TNBS-
treated ileum shows gene profiles indicative of Th17 cell
priming. It has been reported earlier that CCL9 is involved
in the recruitment of CD11b + dendritic cells (DCs) and
that CD11b +DCs preferentially induce Th17 develop-
ment [53,58,59]. Probably in keeping with this finding, is
our observation that Ccl9 together with integrin α M
(Itgam/Cd11b) is increasingly expressed, which points to a
role of CD11b +DCs in the TNBS-treated ileum of Th17
cell development. Furthermore, the increased expression
of S100A8 and S100A9 genes in this model is most likely
related to neutrophil abundance and chemotactic effects
related to innate immunity, which in turn might be linked
to Th17 cell responses, since neutrophils are considered
to be the prime effector cells and inducers of Th17 differ-
entiation [60,61]. We further observed a decreased expres-
sion of transcription factors T-box 21 (Tbx21/Tbet), as
well as of the preferential receptor for Th1 cells, Cxcr3. In
the TNBS-treated ileum, these changes suggest inhibition
of Th1 cell development in favor of Th17 cell develop-
ment, whereby Th17 cells further inhibit the Th1 cell de-
velopment [52,62-64]. About the chemokines and their
receptors, increased expression of Cxcl4, Cxcr3, Ccl2-4,
Ccl9 point to recruitment of immature DCs, T cells,
monocytes or neutrophils [65], while other members of
this group (Cxcl9, Cxcl12, Ccl5, Ccl25 and Ccr6) exhibited
a decreased expression. The repressed expression of Cxcl9
is probably related to the downregulated Th1 responses,
which again is in agreement with the observation that
Th17 cells suppress Th1 cell differentiation [52]. The
decreased expression of Ccl25 is probably associated with
the reduced homing of T cells and IgA + plasma cells to
the intestine, which is consistent with suppression of the
intestinal immune network for IgA production in this
model, as will be discussed later [65]. Another interesting
change that we observed in relation to the cytokines inthis model, was the increased expression of Il33, a ligand
for the IL1 family receptor T1/ST2. IL33 is mainly known
as an inducer of Th2 differentiation, but has recently been
attributed crucial functions in amplifying mucosal innate
rather than acquired immune responses [66,67]. Moving
on to regulatory mechanisms, increased expression of the
Il1 receptor antagonist Il1rn in this model, in the light of
elevated Il1b expression, supports the view of host
mechanisms for the regulation of the IL1 system, as also
observed in IBD [54]. The increased expression of
Thbs1 encoding thrombospondin 1 (THBS1) suggests
that THBS1 is involved in the clearance of inflam-
matory cells in this model [68]. The increased ex-
pression of the regulatory cytokine Il10, retinol-binding
protein 1 (Rbp1) and retinol dehydrogenase 10 (Rdh10)
might be relevant in the light of a recent study demon-
strating that during inflammatory conditions, Th17 cells
of the regulatory phenotype (rTh17) also expressed high
levels of IL10 and that the control of Th17 cells occurs in
the small intestine [69]. These data suggest the in vivo
presence of immunosuppressive activity and reciprocal
regulatory responses in the TNBS-treated ileum, and hence
point to the presence of host mechanisms that tune down
exaggerated pro-inflammatory Th17 responses, in an at-
tempt to reinforce intestinal homeostasis [52,70]. These
findings are in line with previous studies, in which C57BL/6
and other mouse strains were used and which demon-
strated that acute TNBS inflammation is self-limiting, with
a naturally occurring healing response. This healing
response was shown to involve the production of
regulatory cytokines, which thereby cause the inflam-
mation to eventually reach near complete remission
shortly after the acute stage [21,27].
Intestinal immune network for IgA production pathway
and immune response category group
(Additional file 1, Additional file 2, Additional file 7:
Tables S1 and Additional file 8: Table S2).
In the S. mansoni-infected ileum, our results demon-
strate that the intestinal immune network for IgA produc-
tion pathway and immune response category group is
upregulated, conferring defense against toxins and micro-
organisms. The category group shared 3 genes (Il4, Itgb7,
Tnfsf13b), all of which showed increased expression. Using
in vitro methods, Crabtree et al. reported the increased
immunoglobulin production in S. mansoni infections [71].
Probably related to these observations is the increased ex-
pression of the immunoglobulin heavy chain related gene
Ighv6-6 in the S. mansoni-infected ileum.
In the TNBS-treated ileum, our findings suggest that
protective immune responses, the antibody line of
defense and epithelial integrity are affected, leading to
insufficient defense against microorganisms. The cat-
egory group shared 10 genes (Ccl25, Cxcl12, H2-Aa, H2-
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Tnfsf13b), all of which showed decreased expression.
Several other important genes in this functional category
group, such as the polymeric immunoglobulin receptor
(Pigr), interferon regulatory factors, immunoglobulin-
related genes immunoglobulin heavy chain complex
(Igh), Igh-2 and Igh-6, oligoadenylate synthetases, T-cellFigure 3 Illustration of the KEGG complement and coagulation cascad
differentially expressed in the S. mansoni-infected ileum.specific GTPases and immunity-related GTPase family,
M (Irgm), were also found to display decreased expres-
sion. The polymeric immunoglobulin receptor and/or
the secretory immunoglobulins have been reported to be
important in the maintenance of epithelial integrity and
mucosal homeostasis in dextran sulfate sodium (DSS)-
induced mouse model of colitis [72].es pathway with location of 10 associated genes that were
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protein activation cascade category group
(Additional file 1, Additional file 7: Table S1) (Figure 3).
In the S. mansoni-infected ileum, changes in this cat-
egory group suggest complement activation, enhanced
innate immune responses, coagulation activation, altered
vascular homeostasis and affected acute phase responses,
as also observed in some other animal models of intes-
tinal inflammation [73,74]. The category group shared 4Figure 4 Illustration of the KEGG extracellular matrix-receptor interac
differentially expressed in the S. mansoni-infected ileum.genes (C3, C4b, Cfh, F7), all of which showed increased
expression. The changes in complement component fac-
tor h (Cfh) and complement components 3 and 4 (C3,
C4b), indicate enhanced innate immune responses
[75,76]. C3 has also been proposed to have roles in dir-
ectly triggering the degranulation of mast cells, increas-
ing vascular permeability and in smooth muscle
contraction [77]. Perhaps related to this complement
cascade is our observation of the highly increasedtion pathway with location of 5 associated genes that were
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be produced by innate immune cells and involved in
tuning complement activation and inflammation [78].
Furthermore, the increased expression of coagulation
genes Von Willebrand factor homolog (Vwf ) and coagu-
lation factor VII (F7) implies enhanced coagulation,
whereas the decreased expression of the serine peptidase
inhibitor genes and regenerating islet-derived 3 alpha
(Reg3a) suggests affected acute phase responses, since
these genes fall under the acute phase response GO
category.
In the TNBS-treated ileum, this category group did
not show significant changes.
ECM-receptor interaction pathway and cell adhesion
category group
(Additional file 1, Additional file 7: Table S1) (Figure 4).
In the S. mansoni-infected ileum, our results pertaining
to this category group suggest altered vascular homeosta-
sis, recruitment of several types of immune cells,
enhanced ECM turnover leading to altered adhesion, dif-
ferentiation, apoptosis, and proliferation, enhanced tissue
repair and defects in the epithelial barrier. The ECM-
receptor interaction pathway-cell adhesion category group
is upregulated in this condition and shared 5 genes
(Gp1ba, Itgb7, Thbs3, Thbs4, Vwf), all of which showed
increased expression. Increased expression of Vwf and the
VWF-receptor gene glycoprotein 1b, alpha polypeptide
(Gp1ba) is mainly suggestive of destabilization of the
endothelial barrier, increased vascular permeability and
promotion of the inflammatory response [68,74]. The
increased expression of integrins Itgae/Cd103 and Itgb7
(αEβ7) suggests intraepithelial retention of immune cells
in the S. mansoni-infected ileum [79]. As far as other
genes in this category group are concerned, the increased
expression of integrins Itgae//Cd103 and Itgax (Cd11c) in
this model indicates enhanced DC activity [80,81]. How-
ever, another study reported that CD103, despite
displaying an upregulation, is dispensable for intestinal
immunity during helminth infection [82]. Increased ex-
pression of Siglec5 points to the accumulation and survival
of eosinophils [83] and increased expression of collagen-
related gene Col18a1 points to preservation of integrity of
ECM in the basement membrane and hence in wound
healing processes in the S. mansoni-infected ileum [84].
Interestingly, two tight junction protein genes claudin 2
and 8 (Cldn2, Cldn8), which are related to cell adhesion,
showed decreased expression in this model, indicating
alterations in the epithelial paracellular transport [85],
which could be associated with the previously reported
impaired epithelial barrier function and altered permeabil-
ity during S. mansoni infection [86].
In the TNBS-treated ileum, this category group did
not show significant changes.FcεRI signaling pathway and regulation of acute
inflammatory response category group
(Additional file 1, Additional file 7: Table S1).
In the S. mansoni-infected ileum, FcεRI signaling
pathway-regulation of acute inflammatory response cat-
egory group is upregulated, suggesting enhanced stimula-
tion and amplification of mast cell responses and acute
inflammatory responses, such as the Th2 responses,
conferring resistance to schistosome eggs. This particu-
lar category group shared genes, such as Fcer1a and Il4,
and these genes showed increased expression. Fc recep-
tor IgE high affinity I α polypeptide (Fcer1a), is known
to encode the high-affinity IgE receptor subunit α, and
to be expressed on mast cells and granulocytes [87].
Acute schistosomiasis is characterized by strong host
immune responses with elevated IgE levels correlating
with the magnitude of the infection [88]. The inter-
action of antigen with IgE bound to FcεRI triggers mast
cells to degranulate, resulting in the release of increased
levels of mediators that modulate immune responses
and increase smooth muscle contraction and vascular
permeability [89]. In line with these findings, we
observed increased expression of several mast cell-
associated genes, such as the mast cell chymases 1, 2
(Cma1, Cma2), and the mast cell proteases Mcpt1,
Mcpt2, Mcpt4 and Mcpt9 in this model, along with the
afore-mentioned Fcer1a. These findings corroborate the
results of another study that reported the predominant
recruitment of mucosal mast cells expressing mouse
mast cell protease 1 (mMCP-1), a protein encoded by
Mcpt9, in acute intestinal schistosomiasis [90]. A crucial
role for chymase immunopositive-mast cells has also been
reported in the pathophysiology of CD [91]. A positive
feedback mechanism between FcεRI signaling and IL4
production has been described, and indeed, as discussed
earlier, Il4 was increasingly expressed in the S. mansoni-
infected ileum [92].
The TNBS-treated ileum did not reveal any significant
changes related to this category group, which is not sur-
prising given the known role of the Fcε receptor in aller-
gic reactions and defense against parasitic infections,
which is not the case in acute TNBS-induced ileitis.
Antigen processing and presentation pathway and
antigen processing and presentation (of endogenous
antigen, of exogenous peptide antigen and of peptide or
polysaccharide antigen via MHC class II) category group
(Additional file 2, Additional file 8: Table S2) (Figure 5).
In the S. mansoni-infected ileum, no significant
changes were observed in this category group.
In the TNBS-treated ileum, the altered gene expres-
sion observed in this category group indicates that anti-
gen processing and presentation are defective in acute
TNBS-induced ileitis. This category group shared 13
Figure 5 Illustration of the KEGG antigen processing and presentation pathway with location of 20 associated genes that were
differentially expressed in the TNBS-treated ileum.
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H2-DMb2, H2-Eb1, H2-K1, H2-Ob, H2-Q7, H2-T23,
Tap2, Tapbp), all of which showed decreased expression.
Apart from the above-mentioned MHC class I and class
II antigen genes, other genes in this category group, such
as Cd8a T cell gene and the T cell receptor genes Tcra
and Tcrg-V4 also showed decreased expression. The earl-
ier reported downregulation of histocompatibility 2,
class II antigen E β (H2-Eb1) and of T cell receptor γ in
a C57BL/6 mouse model of TNBS-induced colitis is
therefore in agreement with our observations [93]. These
changes point to defective antigen presentation,
decreased cytotoxic T cell function and the suppression
of unconventional regulatory T cells, such as the resident
TCRγδ or TCRαβ CD8+ intraepithelial lymphocytes
[94]. The decreased expression of heat shock protein 2
(Hspa2), which encodes HSP70A2, along with the
increased expression of Hspb1 (HSP25), is indicative of achange in the inherent ability of epithelial cells to defend
themselves against cellular stress and injury in acute
TNBS-induced ileitis. Hspa2 downregulation also hints
at decreased antigen presentation to CD4+ T cells by
antigen presenting cells [95].
Cell adhesion molecules pathway and cell adhesion
category group
(Additional file 2, Additional file 8: Table S2).
In the S. mansoni-infected ileum, no significant
changes were observed in this category group.
In the TNBS-treated ileum, changes in this category
group suggest affected integrity and function of the in-
testinal epithelial barrier and altered recruitment of sev-
eral types of immune cells. This particular category
group shared 8 genes (Cd6, Cldn2, Cldn8, Itga8, Itgb7,
Negr1, Neo1, Ptprf ), all of which showed decreased ex-
pression. Changes related to these claudin genes have
Figure 6 Illustration of the KEGG ABC transporters pathway
with location of 14 associated genes that were differentially
expressed in the TNBS-treated ileum.
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[85,96]. Decreased expression of integrin beta 7 (Itgb7)
together with the afore-mentioned Ccl5 in this model
indicates suppression of lymphocyte recruitment to the
intestine [97]. Furthermore, changes in some other genes
in this category group, such as the decreased expression
of Itgae/Cd103, together with increased expression of
Itgam, and of the afore-mentioned Ccl9, indicate the loss
of CD103+ intestinal DCs, as seen in murine colitis
models [98], and an increased efflux of activated macro-
phages and DCs to the lymphatics. These changes are per-
haps instrumental in the restoration of homeostatic balance
through T cell induction in the TNBS-treated ileum [59,99].
Increased expression of genes encoding proteins such as
laminin and decreased expression of genes encoding col-
lagens, integrins α11, and tenascin in the cell adhesion cat-
egory are mainly suggestive of compositional changes in the
epithelial basement membrane and interstitial matrix and
suppressed wound healing [100,101].
TLR signaling pathway and immune, inflammatory
response category group
(Additional file 2, Additional file 8: Table S2).
In the S. mansoni-infected ileum, this TLR-associated
category group did not show differential expression,
which is in accordance with previous reports stating that
antigen secretions of schistosoma eggs, such as the sol-
uble egg antigen, do not require the expression of TLR2
or TLR4 on DCs to induce a polarized Th2 response
[102]. Instead, pattern recognition receptor genes other
than TLRs, such as the C-type lectin family member
genes showed increased expression, confirming that C-
type lectins are likely involved in innate signaling in
acute intestinal schistosomiasis [102].
In the TNBS-treated ileum, changes in this category
group suggest altered innate immune responses, sup-
pressed barrier protection and aggravated inflammatory
responses. The category group shared 6 genes that
showed increased expression (Ccl3, Ccl4, Cd14, Il1b, Il6,
Tlr6) and 5 shared genes that showed decreased expres-
sion (Ccl5, Cxcl9, Irf7, Tlr1, Tlr3). Upregulation of TLR6
has been suggested to lead to pathogen recognition and
rapid activation of innate immunity by the induction of
inflammatory molecules [103]. The increased expression
of Il6, Il1b, Ccl3 (Mip-1α), Ccl4 (Mip-1β) is probably
related to this finding. TLR1 expression has been shown
to be downregulated in human inflamed colonic epithe-
lial and lamina propria cells and has been linked to
responses to TLR2 ligands [104]. A protective role for
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of intestinal inflammation in a murine acute colitis
model [105]. Therefore, the observed decreased expres-
sion of Tlr3 in our study probably indicates suppression
of protective TLR3 signaling. Another interesting gene
in this functional category group, which was found to be
highly expressed in the TNBS-treated ileum, is secreted
phosphoprotein 1 (Spp1), and the protein encoded by
this gene is known to be a key immune modulator,
stimulating stress responses as well as both pro- and
anti-inflammatory processes [106].
ABC transporters pathway and response to chemical
stimulus category group
(Additional file 2, Additional file 8: Table S2) (Figure 6).
In the S. mansoni-infected ileum, this category group
did not show significant changes.
In the TNBS-treated ileum, changes in this category
group suggest a defective efflux of pathogens, drugs and
toxins, thereby an impaired epithelial barrier function,
an enhanced response to chemical stimuli and altered
vascular homeostasis. This category group shared 3
genes (Abca1, Abcb11, Abcc1) with increased expression.
Other genes in this functional category group that
showed decreased expression included Abca1, Abcb10,
Abcb11, Abcc1, Abcc3, Abcc4, Abcg2, Tap1 and Tap2.
The ATP-binding cassette sub-family B member 1,
(Abcb1a), which has been observed to change expression
in models of colitis and CD [4,107], was not found to be
differentially expressed. Other changes related to this
category group included those of the coagulation cas-
cade, which seems to be activated given the increased
expression of coagulation factors III and XIII (F3, F13),
the plasminogen activator, the urokinase receptor
(Plaur) and some serine (or cysteine) peptidase inhibitor
members. These changes lend further link to previous
studies that have demonstrated that TNBS administra-
tion causes bleeding within the ileal wall [30] and to the
existing role of coagulation in the perpetuation of in-
flammation, as also reported in human and experimental
IBD [68,73].
Comparison of the differentially expressed genes in our
study with IBD
Comparison of the differentially expressed genes in the
S. mansoni-infected ileum with 32 genes that have previ-
ously been shown to exhibit an altered expression pattern
in murine models of IBD [4] yielded only 1 overlapping
gene (1 upregulated) in the S. mansoni-infected ileum; i.e.,
Timp1. This change in Timp1 expression might be
related to an altered epithelial barrier and tissue remod-
eling [108]. It can be inferred from the comparison that
the S. mansoni-infected ileum, which is a model of intes-
tinal inflammation not related to IBD, hardly shows anysimilarity with IBD-associated gene expression. The change
in Timp1 expression was also observed in the TNBS-
treated ileum (see below), implying that activity of this
gene is probably not specific to the inflammation type.
In the TNBS-treated ileum, however, comparison with
the above-mentioned 32 genes [4], yielded 14 overlap-
ping genes (12 upregulated and 2 downregulated). The
higher expressed genes were Il6, Ccl2, Ccl3, Ccl4, Cxcl5,
Mmp3, Mmp7, Mmp9, Timp1, S100a8, S100a9 and Ptgs2
and the lower expressed genes were Ccl5 and Cxcr3.
Increased expression of Il6, chemokines and neutrophil-
associated genes, are indicative of pro-inflammatory
responses and the recruitment of macrophages and
granulocytes, as mentioned above. Changes in the ex-
pression of matrix metalloproteinases and of the tissue
inhibitor of metalloproteinase 1 (Timp1) are probably
related to tissue injury, tissue remodeling, angiogenesis,
and promotion of leukocyte extravasation observed in
this model [108]. Increased expression of Ptgs2 points to
prostaglandin synthesis, as suggested in colonic epithe-
lial cells in IBD and in experimental colitis [4]. It can be
inferred from the comparison that although our TNBS-
induced ileitis model is an acute insult, 14 genes (out of
the 32 genes previously known to show an altered ex-
pression pattern in murine models of IBD [4]) showed
changed expression; and as such, the expression profile
in this model bears considerable relevance to that of
IBD. A study of murine TNBS-induced inflammation in
colon, conducted by another group, however, revealed
very few differentially expressed genes and did not show
significant similarities with the expression profile in
human IBD [4]. The divergent results in this respect be-
tween the latter and our study may originate from sev-
eral factors, such as the use of a different mouse strain,
the application of different dosages, the region studied
(colon vs. ileum,) and the type of inflammation (only
delayed type hypersensitivity reaction after administra-
tion of a second dose vs. acute inflammation in our
study). Our study, compared to previously published
studies such as the one mentioned above [4], as well as
some others [109], highlight the significant differences of
results in gene expression in the same inflammatory
condition, i.e., in TNBS-induced inflammation, but in
other regions of the GI tract and therefore strengthen
the need of studies such as ours, to account for the
region-specific differences. Furthermore, comparison of
the differentially expressed genes in our study with the
list of 77 candidate genes located within IBD susceptibil-
ity loci [109-112] did not yield any overlapping genes in
the S. mansoni-infected ileum, whereas 9 genes (4 up
and 5 down) were overlapping in the TNBS-treated
ileum (Table 1).
This brief comparative analysis with IBD-related or
IBD-associated genes, clearly demonstrates that gene
Table 1 Comparison of the differentially expressed genes in
the S. mansoni-infected and the TNBS-treated ileum with







NOD2 CD ND ND
ATG16 CD ND ND
IRGM CD ND ↓
LRRK2 CD ND ND
PTPN22 CD ND ND
CCR6 CD ND ↓
IL-2RA CD ND ND
IL-18RAP CD ND ND
IL-27 CD ND ND
ERAP2 (Erap1/Eraap) CD ND ND
ITLN1 CD ND ND
CCL2 (Ccl12) CD ND ND
CCL7 CD ND ND
TNFSF11 CD ND ND
BACH2 CD ND ND
TAGAP CD ND ND
VAMP3 CD ND ND
DENNDIB CD ND ND
DNMT3A CD ND ND
GCKR CD ND ND
THADA CD ND ND
SP140 CD ND ND
PRDX5 CD ND ND
ZFP36L1 CD ND ND
ZMIZ1 CD ND ND
MUC1 CD ND ND
SCAMP3 CD ND ND
CPEB4 CD ND ND
FADS1 CD ND ND
SLC22A5 CD ND ND
ECM1 UC ND ND
HNF4A UC ND ND
CDH1 UC ND ND
LAMB1 UC ND ND
GNA12 UC ND ND
IFNG UC ND ND
IL-26 (Il-22) UC ND ND
IL-8RA/IL-8RB UC ND ↑
IL-2 UC ND ND
IL-21 UC ND ND
IL-7R UC ND ND
TNFRSF9 UC ND ND
Table 1 Comparison of the differentially expressed genes in
the S. mansoni-infected and the TNBS-treated ileum with
candidate genes located within IBD susceptibility loci
(Continued)
TNFRSF14 UC ND ↓
FCGR2A (Fcgr3/Fcgr2b) UC ND ND
IRF5 UC ND ND
LSP1 UC ND ND
OTUD3 UC ND ND
PLA2G2E UC ND ND
DAP UC ND ND
PIM3 UC ND ND
CAPN10 UC ND ND
IL-23R CD/UC ND ND
IL-12B CD/UC ND ND
STAT3 CD/UC ND ↑
AK2 CD/UC ND ND
TYK2 CD/UC ND ND
NKX2-3 CD/UC ND ND




ORMDL3 CD/UC ND ND
RTEL1 CD/UC ND ND
PTGER4 CD/UC ND ↓
KIF21B CD/UC ND ND
CDKAL1 CD/UC ND ND
ZNF365 (Zfp365) CD/UC ND ND
HLA-DRB1 (H2-Eb1) CD/UC ND ↓
MST1 CD/UC ND ND
IL-10 CD/UC ND ↑
CARD9 CD/UC ND ND
REL CD/UC ND ND
PRDM1 CD/UC ND ND
TNFSF15 CD/UC ND ND
ICOSLG (Icosl) CD/UC ND ND




SMAD3 CD/UC ND ND
PTPN2 CD/UC ND ND
The table compares candidate genes within IBD susceptibility loci to the
differentially expressed genes in the S. mansoni-infected and in the TNBS-
treated ileum. Gene symbol denotes the gene symbol in human along with
the murine homologue where applicable in brackets. CD, human Crohn's
disease; UC, human ulcerative colitis; ND, no difference; ↑, upregulated; ↓,
downregulated. No genes were overlapping in the S. mansoni-infected ileum,
while 9 genes were overlapping in the TNBS-treated ileum.
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our study have noticeable relevance to IBD.
Conclusions
The present study in mouse is the first to identify changes
in whole-genome gene expression in the acutely inflamed
ileum of two murine models of intestinal inflammation
and to characterize the biological relevance related to
these changes. The results demonstrate that gene expres-
sion profiles and patterns are considerably distinct in the
two models owing to the differences in etiology. The
results suggest that acute intestinal schistosomiasis shows
enhanced Th2 responses, whereas acute TNBS-induced
ileitis exhibits Th17 cell priming. Although two functional
category groups (cytokine-cytokine receptor interaction
pathway-immune response category group and intestinal
immune network for IgA production pathway-immune re-
sponse category group) are common to both models of in-
flammation, the predisposing genes are largely unique
within the pathways. Other functional category groups,
such as the complement and coagulation cascades
pathway-protein activation cascade, ECM-receptor inter-
action pathway-cell adhesion, Fc epsilon RI signaling
pathway-acute inflammatory response are unique to the
acute intestinal schistosomiasis model, and are upregu-
lated, whereas antigen processing and presentation, cell
adhesion, TLR signaling pathway-immune and inflamma-
tory response and ABC transporters pathway-response to
chemical stimulus category groups are unique to the acute
TNBS-induced ileitis model, and are more bent towards
downregulation. All the above findings underscore the dis-
tinct gene expression patterns in the two inflammation
models of our study. Acute intestinal schistosomiasis
seems to promote a number of specific processes, such as
complement-mediated innate immunity, protein activa-
tion, ECM turnover, acute inflammatory responses as well
as antibody-mediated defense responses. Acute TNBS-
induced ileitis seems to be associated with aspecific proin-
flammatory responses, alterations in TLR-mediated innate
immunity, defective antigen processing and presentation,
angiogenesis and anti-angiogenesis, reduced cytotoxic T
cell function, compositional changes in the epithelial base-
ment membrane and interstitial matrix, enhanced tissue
remodeling and a defective antibody line of defense.
Altered vascular homeostasis and impaired epithelial bar-
rier function seem to be common features in both models
of inflammation. The gene expression profiles in acute
TNBS-induced ileitis show considerable relevance to
those of IBD. This is of course no complete resemblance,
but insight into the differences between animal models
and the human situation is equally important. Further-
more, better characterization of animal models leads to
better interpretation of results concerning translational re-
search. In addition to the above findings, the present studyrevealed a differentially expressed gene list that includes
many genes for which pathways or functional annotations
have not yet been defined. Therefore, the comprehensive
differential gene list together with the functional grouping,
in particular, provided by this study offers a valuable re-
source and a starting point to explore extended functional
networks, new targets or a specific novel pathway in
greater detail related to small bowel inflammation. Future
application of these analyses to other ileal inflammation
models, including chronic stages and other time points,
will yield greater insights and lead to a better understand-
ing of ileal inflammation.Additional files
Additional file 1: Complete list of differentially expressed genes in
the S. mansoni-infected ileum. Differentially expressed genes in the S.
mansoni-infected ileum are represented with their ID (Agilent probe ID),
GB_ACC (gene bank accession), GENE_SYMBOL (gene symbol),
GENE_NAME (gene name), log2FC (log2 fold change), p-value and
adjusted p-value. Upregulated genes are shown in red; downregulated
genes are shown in green; overlapping genes that changed in the same
direction as in the TNBS-treated ileum are displayed in bold; overlapping
genes that changed in the opposite direction to that of the TNBS-treated
ileum are underlined. All genes listed in this file showed significant
differential expression (p-value < 0.05, adjusted p-value < 0.1 and log2 fold
change > 1 or < −1) relative to controls.
Additional file 2: Complete list of differentially expressed genes in
the TNBS-treated ileum. Differentially expressed genes in the TNBS-
treated ileum are represented with their ID (Agilent probe ID), GB_ACC
(gene bank accession), GENE_SYMBOL (gene symbol), GENE_NAME (gene
name), log2FC (log2 fold change), p-value and adjusted p-value.
Upregulated genes are shown in red; downregulated genes are shown in
green; overlapping genes that changed in the same direction as in the S.
mansoni-infected ileum are displayed in bold; overlapping genes that
changed in the opposite direction to that of the S. mansoni-infected
ileum are underlined. All genes listed in this file showed significant
differential expression (p-value < 0.05, adjusted p-value < 0.1 and log2 fold
change > 1 or < −1) relative to controls.
Additional file 3: Complete list of differentially expressed genes
that could be annotated with a KEGG pathway term and/or a GO
term in the S. mansoni-infected ileum. Differentially expressed genes
are listed together with their KEGG and/or GO annotations. GenID
(Ensembl ID), Symbol (gene symbol), #GO-Terms Associated (number of
GO terms associated), Percent GO-Terms Associated, UID-str (unique
Agilent ID), GO Names (names of associated terms). Of the 207 unique
genes that were differentially expressed in the S. mansoni-infected ileum,
42 genes could be linked to a KEGG pathway term and 144 genes could
be linked to a GO term.
Additional file 4: Complete list of differentially expressed genes
that could be annotated with a KEGG pathway term and/or a GO
term in the TNBS-treated ileum. Differentially expressed genes are
listed together with their KEGG and/or GO annotations. GenID (Ensembl
ID), Symbol (gene symbol), #GO-Terms Associated (number of GO terms
associated), Percent GO-Terms Associated, UID-str (unique Agilent ID), GO
Names (names of associated terms). Of the 1417 unique genes that were
differentially expressed in the TNBS-treated ileum, 232 genes could be
linked to a KEGG pathway term and 1050 genes could be linked to a GO
term.
Additional file 5: KEGG pathways and GO (biological process)
categories that were over-represented in the S. mansoni-infected
ileum. KEGG pathways and GO (biological process) categories that were
over-represented in the S. mansoni-infected ileum are represented with
their MAPP Name (KEGG pathway name), Z score (z-score), AdjustedP
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method)), gene symbols, AVG-logFC (average log2FC for each enriched
term calculated based on associated differential genes) and AVG-adj.P. Val
(average adjusted p-value for each enriched term calculated based on
associated differential genes, GOID (Gene ontology ID), GO Name (name
of GO category). Threshold criteria for over-representation: z-score > 2, at
least three genes from the input list in the enriched category, an
adjusted permutation p-value ≤ 0.35. Top-scoring functional category
groups for KEGG pathway and GO categories are shown in colour as
follows: Cytokine-cytokine receptor interaction pathway and immune,
defense response category group. Intestinal immune network for IgA
production pathway and immune response category group.
Complement and coagulation cascades pathway and protein activation
cascade category group. ECM-receptor interaction pathway and cell
adhesion category group. Fc epsilon RI signaling pathway and acute
inflammatory response category. (Note: Although immune response
category is common to more than one category group, it is coloured
only once).
Additional file 6: KEGG pathways and GO (biological process)
categories that were over-represented in the TNBS-treated ileum.
KEGG pathways and GO (biological process) categories that were over-
represented in the TNBS-treated ileum are represented with their MAPP
Name (KEGG pathway name), Z score (z-score), AdjustedP (adjusted
permutation p-value calculated using the Benjamini-Hochberg method)),
gene symbols, AVG-logFC (average log2FC for each enriched term
calculated based on associated differential genes) and AVG-adj.P. Val
(average adjusted p-value for each enriched term calculated based on
associated differential genes, GOID (Gene ontology ID), GO Name (name
of GO category). Threshold criteria for over-representation: z-score > 2, at
least three genes from the input list in the enriched category, an
adjusted permutation p-value ≤ 0.35. Top-scoring functional category
groups for KEGG pathway and GO categories are shown in colour as
follows: Cytokine-cytokine receptor interaction pathway and
inflammatory, immune response category group. Intestinal immune
network for IgA production pathway and immune response category
group. Antigen processing and presentation pathway and antigen
processing and presentation category group. Cell adhesion molecules
pathway and cell adhesion category group. Toll-like receptor signaling
pathway and immune and inflammatory response category group. ABC
transporters pathway and response to chemical stimulus category group.
(Note: Although immune, inflammatory response categories are common
to more than one category group, they are coloured only once).
Additional file 7: Table S1. High scoring functional category groups in
the S. mansoni-infected ileum.
Additional file 8: Table S2. High scoring functional category groups in
the TNBS-treated ileum.
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